RFK Jr. ACIP: Flu & MMRV Vaccine Review
- WASHINGTON — A panel of vaccine advisers, handpicked by health and Human Services Secretary Robert F.
- kennedy recently overhauled the panel, appointing eight new members.
- Next week's meeting will include votes on recommendations for flu vaccines containing thimerosal.
Robert F. Kennedy Jr.’s vaccine advisory panel is under the microscope. Next week, the newly appointed panel will review approved vaccines, specifically flu vaccines and the MMRV vaccine. This follows Kennedy’s dismissal of the original panel, raising questions about the future of vaccine recommendations. This critical review may reconsider the role and use of the MMRV vaccine for children under 5, which is a major shift in recommendations. The updated agenda of the advisory Committee on Immunization Practices (ACIP) suggests the potential for critically important changes to vaccination guidelines. The panel, now comprised of members with varying views on vaccine safety, will influence future health decisions. Read more from News Directory 3. How will these changes affect public health? Discover what’s next …
Vaccine Panel’s Role Under Scrutiny After Kennedy Appointments
WASHINGTON — A panel of vaccine advisers, handpicked by health and Human Services Secretary Robert F. Kennedy Jr., is set to review two already-approved vaccines at its first meeting next week. The agenda for the meeting was released Wednesday.
kennedy recently overhauled the panel, appointing eight new members. Some of these members have publicly questioned the safety and efficacy of approved vaccines.The advisory committee’s role is to provide guidance on immunization practices.
Next week’s meeting will include votes on recommendations for flu vaccines containing thimerosal. the panel will also reconsider the use of the combined measles,mumps,rubella,and varicella (MMRV) vaccine for children younger than 5.
The updated agenda from the advisory Committee on Immunization Practices (ACIP) follows Kennedy’s dismissal of all 17 members of the autonomous panel a week prior. This panel advises the Centers for Disease Control and Prevention (CDC) on vaccine recommendations.